CD4 and neoplasm: These results support that M002-programmed CD4+ T cells favored trafficking to the tumor and had enhanced expansion and functionality to control tumor growth, likely via an MHCII-mediated interaction with tumor cells, consistent with our earlier in vitro killing assays (Fig. 3b–d).